PaceMate announced today that it acquired the Paceart Optima on-premises cardiac workflow solution from Medtronic
(NYSE: MDT)
.
The acquisition expands PaceMate’s global reach by adding nearly 1,000 clinic locations worldwide. Sarasota, Florida-based PaceMate said it enhances its ability to provide its comprehensive cardiac remote monitoring solution and cardiac data management.
Medtronic’s Cardiac Rhythm Management (CRM) business and PaceMate intend to collaborate closely to ensure a seamless transition.
“After a comprehensive evaluation, we are confident PaceMate is the best organization to service Paceart customers and their future cardiac data workflow needs,” said Dr. Kweli P. Thompson, SVP and president, Medtronic CRM. “PaceMate offers best-in-class cardiac data management solutions and will provide excellent ongoing support to Paceart customers.”
PaceMate offers an end-to-end platform for supporting the full spectrum of cardiac devices. That includes implantables, ambulatory monitors, heart failure devices and remote patient monitors. The company pairs this with a complete suite of solutions, including software, patient communications and clinical service support.
The flagship PaceMateLIVE remote cardiac monitoring product, uses EHR integrations for seamless implementation, intuitive use and intelligent patient prioritization.
According to PaceMate, acquiring the Medtronic solution complements its own offerings, bringing it to the forefront of cardiac care. The company believes it could enable better patient outcomes and global innovation.
“Our shared values, dedication to customer experience, and commitment to exceptional patient-centric cardiac solutions make this agreement a perfect fit,” said Tripp Higgins, CEO of PaceMate. “Paceart customers will benefit from the continued support of Paceart employees transitioning to PaceMate, as well as enhanced service delivery and innovation. We are excited to set a new standard in the market by combining the strengths of both technologies for unparalleled support and advancement.”
